Bruce & Co’s Organon & Co OGN Stock Holding History

Bruce & Co’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-31,200	Closed	-$465K	–	43
2025 Q1	$465K	Hold	31,200	–	–	0.15%	37
2024 Q4	$466K	Sell	31,200 -170	-0.5%	-$2.77K	0.15%	37
2024 Q3	$600K	Hold	31,370	–	–	0.17%	36
2024 Q2	$649K	Buy	31,370 +180	+0.6%	+$3.58K	0.21%	34
2024 Q1	$586K	Hold	31,190	–	–	0.19%	35
2023 Q4	$450K	Hold	31,190	–	–	0.16%	35
2023 Q3	$541K	Sell	31,190 -280	-0.9%	-$5.84K	0.18%	33
2023 Q2	$655K	Hold	31,470	–	–	0.18%	31
2023 Q1	$740K	Hold	31,470	–	–	0.2%	31
2022 Q4	$879K	Sell	31,470 -500	-2%	-$12.8K	0.23%	29
2022 Q3	$748K	Hold	31,970	–	–	0.21%	29
2022 Q2	$1.08M	Hold	31,970	–	–	0.25%	28
2022 Q1	$1.12M	Sell	31,970 -400	-1%	-$13.7K	0.23%	29
2021 Q4	$985K	Hold	32,370	–	–	0.2%	27
2021 Q3	$1.06M	Buy	+32,370	New	+$1.04M	0.23%	27

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Bruce & Co's OGN Position: Q2 2025 in Review

Bruce & Co sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 31,200 shares — an estimated $465K sold.

Bruce & Co first reported a position in OGN in Q3 2021 and held it in 15 quarters. The position peaked at $1.12M in Q1 2022. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

Bruce & Co reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
Bruce & Co sold 31,200 Organon & Co shares in Q2 2025, an estimated $465K.
Bruce & Co first reported a position in Organon & Co in Q3 2021 and held it in 15 quarters.
Bruce & Co's Organon & Co position peaked at $1.12M in Q1 2022.
695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Bruce & Co's 13F filing for Q2 2025, filed 14 Aug 2025.